Biokinetics Study for F-18 FDG in Pediatric Molecular Imaging
Stopped No subjects who met the study criteria agreed to participate in two years prior to the COVID-19 crisis.
Conditions
Interventions
- OTHER: Modification in acquisition protocol
- DRUG: F-18 Fluorodeoxyglucose
Sponsor
Boston Children's Hospital
Collaborators
- [object Object]
- [object Object]
- [object Object]